BR100 Increased By (0.43%)
BR30 Increased By (0.38%)
KSE100 Increased By (0.27%)
KSE30 Increased By (0.14%)
BECO 6.03 No Change ▼ 0.00 (0%)
BML 57.36 Increased By ▲ 4.61 (8.74%)
BOP 34.18 Decreased By ▼ -0.07 (-0.2%)
CNERGY 8.20 Increased By ▲ 0.04 (0.49%)
DCL 12.12 Decreased By ▼ -0.22 (-1.78%)
FCCL 54.00 Increased By ▲ 0.11 (0.2%)
FCSC 5.30 Increased By ▲ 0.08 (1.53%)
FFL 18.05 Increased By ▲ 0.02 (0.11%)
FNEL 1.31 Increased By ▲ 0.01 (0.77%)
HUMNL 11.23 Increased By ▲ 0.23 (2.09%)
KEL 8.15 Increased By ▲ 0.04 (0.49%)
KOSM 5.46 Increased By ▲ 0.08 (1.49%)
MLCF 88.72 Increased By ▲ 0.67 (0.76%)
NBP 186.30 Decreased By ▼ -0.18 (-0.1%)
PACE 10.90 Increased By ▲ 0.18 (1.68%)
PAEL 40.56 Increased By ▲ 0.62 (1.55%)
PIAHCLA 26.30 Increased By ▲ 0.13 (0.5%)
PIBTL 17.30 Decreased By ▼ -0.02 (-0.12%)
PPL 232.60 Decreased By ▼ -0.18 (-0.08%)
PRL 34.90 Decreased By ▼ -0.05 (-0.14%)
PTC 66.80 Decreased By ▼ -0.76 (-1.12%)
SEARL 91.59 Increased By ▲ 0.66 (0.73%)
SSGC 27.18 Increased By ▲ 0.01 (0.04%)
TELE 8.56 Decreased By ▼ -0.01 (-0.12%)
THCCL 64.40 Increased By ▲ 4.27 (7.1%)
TPLP 9.15 Increased By ▲ 0.39 (4.45%)
TREET 24.72 Increased By ▲ 0.18 (0.73%)
TRG 72.59 Increased By ▲ 0.84 (1.17%)
WAVES 10.80 Increased By ▲ 0.82 (8.22%)
WTL 1.28 Increased By ▲ 0.02 (1.59%)
By

LONDON: England's health service said it will expand its COVID-19 booster vaccination programme to include 16- and 17-year-olds from Monday.

Until now, booster jabs have been limited to 16- and 17-year-olds most at risk from the coronavirus.

"More than four in five adults in England have already been boosted, helping to protect them from severe illness," British health minister Sajid Javid said in a statement.

"We're now extending the programme to 16- and 17-year-olds so they can top-up their immunity this winter to keep themselves and their friends safe."

England cuts Covid isolation period to boost economy

Since the vaccination programme rolled out to the age group in August, more than 889,700 teenagers - or seven in 10 people aged 16 and 17 - have had their first dose and more than 600,000 have had their second.

Comments

Comments are closed for this article.